✦ LIBER ✦

Debate: Leave the effusion alone: treatment of parapneumonic effusion – Con

✍ Scribed by Y. Sivan

Book ID: 114412429
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 50 KB
Volume: 13
Category: Article
ISSN: 1526-0550
DOI: 10.1016/s1526-0542(12)70033-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intrapleural Tissue Plasminogen Activato

Intrapleural Tissue Plasminogen Activator for the Treatment of Parapneumonic Effusion

✍ Susan E. Hamblin; Douglas L. Furmanek 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Intrapleural streptokinase for the treat

Intrapleural streptokinase for the treatment of complicated parapneumonic effusion and empyema in 2 newborns

✍ Avidan Kizilelma Yigit; Yavuz Yilmaz; Omer Erdeve; Ismail Kursad Gokce; Serife S 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 428 KB

Efficacy of Intrapleural Tissue-type Pla

Efficacy of Intrapleural Tissue-type Plasminogen Activator in the Treatment of Loculated Parapneumonic Effusions

✍ Zuckerman, Darryl A.; Reed, Michael F.; Howington, John A.; Moulton, Jonathan S. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 395 KB

Cefuroxime vs a Dicloxacillin/Chloramphe

Cefuroxime vs a Dicloxacillin/Chloramphenicol Combination for the Treatment of Parapneumonic Pleural Effusion and Empyema in Children

✍ G.C. Palacios; S.N. Gonzalez; F.L. Perez; S.F. Cuevas; S.F. Solorzano 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Ultrasound Imaging to Predict the Progno

Ultrasound Imaging to Predict the Prognosis of Small-bore Chest Tube Treatment for Empyema and Complicated Parapneumonic Effusion

✍ Chen, Chia-Hung; Hsu, Wu-Huei 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 489 KB

A comparative trial of LC9018 plus doxor

A comparative trial of LC9018 plus doxorubicin and doxorubicin alone for the treatment of malignant pleural effusion secondary to lung cancer

✍ Tomiya Masuno; Susumu Kishimoto; Takeshi Ogura; Takeshi Honma; Hisanobu Niitani; 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

The efficacy and safety of intrapleural LC9018 (Yakult Co. Ltd., Tokyo, Japan) with or without doxorubicin (Adriamycin; Adria Laboratories, Columbus, OH) were evaluated in a randomized, controlled trial performed in 95 patients with malignant pleural effusions secondary to lung cancer. Seventy-six p